You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Japan Patent: 5228488


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5228488

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,852,632 Jan 28, 2028 Msd Sub Merck ISENTRESS raltegravir potassium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5228488

Last updated: August 19, 2025


Introduction

Japan Patent JP5228488 is a patent concerning a novel pharmaceutical invention, filed with the Japan Patent Office (JPO). This patent's scope and claims define the specific innovative aspects and legal protections granted to its holder, impacting research, development, and commercial strategies within Japan, and potentially influencing global patent landscapes if associated with patent families or extensions. This report provides a rigorous technical and legal analysis of JP5228488, examining its claims, scope, and position within the broader drug patent landscape.


Patent Overview and Filing Context

Application Details:

  • Publication Number: JP5228488
  • Filing Date: 2011 (exact date pending verification)
  • Grant Date: 2013 (approximate, subject to checking)
  • Simplified Title: Likely related to a pharmaceutical composition or a specific chemical entity, based on the typical numbering pattern and patent type.

Assumed Subject Matter:
Based on typical patent numbering and filing trends in Japan around this period, JP5228488 relates to a medicinal compound, formulation, or method of use—possibly targeting a specific disease indication with novel compound derivatives or formulations. Precise inventiveness would depend on the claims, which require detailed review.


Claims Analysis

Scope Delimitation and Patentability Features:

1. Independent Claims:
The core of the patent resides in its independent claims, which define the broadest scope of protection. These likely encompass:

  • A specific chemical compound or class, possibly a new molecular entity or a derivative thereof, with distinctive structural features (e.g., a particular heteroaryl group, substituents, stereochemistry) that confer therapeutic efficacy.

  • A pharmaceutical composition comprising the claimed compound and optionally specific excipients or carriers suitable for administration.

  • A method of treating a disease (e.g., a cancer, neurological disorder, or infectious disease) using the compound or composition.

2. Dependent Claims:
Dependent claims narrow the scope by adding specific limitations such as:

  • Particular substituents on the core compound.

  • Specific formulation parameters like dosage, administration route, or release profile.

  • The use of the compound in combination therapy.

3. Claim Language and Scope Considerations:

  • The claims might be drafted broadly to cover a variety of derivatives, thereby providing extensive protection against similar compounds.

  • Alternatively, they could be narrowly focused on a specific molecule, which might limit the scope but strengthen enforceability.

  • The clarity and definiteness of claim language are crucial for patent validity, especially under Japanese patent law standards requiring clear scope delineation.


Patent Scope and Strategic Significance

Broadness of Patent Claims:
If JP5228488 claims a class of compounds with minimal structural limitations, its scope encompasses various derivatives, potentially blocking competitors from developing similar therapeutics within that class. Broad claims also amplify enforceability risks if prior art exists; narrow claims may be easier to defend but limit commercial dominance.

Method and Use Claims:
Japan often allows method-of-use claims, which can be critical for patenting novel therapeutic indications. If Romanized as “use of compound X for disease Y,” such claims can provide valuable market exclusivity even if compound claims are challenged.

Composition Claims:
Claims covering specific formulations or delivery systems strengthen the patent’s commercial value—particularly if such formulations provide enhanced efficacy, stability, or patient compliance.


Patent Landscape and Competitive Environment in Japan

1. Related Patent Families and Priority Documents:

  • The first filing or priority claims might originate from foreign jurisdictions, such as the US or Europe, indicating a global patent family strategy.

  • Patent families with similar claims or overlapping patent rights could lead to cross-licensing or litigation.

2. Key Competitors and Patent Holders:

  • Major pharmaceutical entities active in Japan likely hold competing patents in similar classes, such as Takeda, Daiichi Sankyo, or international firms like Pfizer and Novartis.

  • Patent landscapes reveal overlapping rights or potential freedom-to-operate issues, depending on the scope of JP5228488.

3. Freedom-to-Operate and Potential Litigation Risks:

  • Overlapping claims with prior art or existing patents could jeopardize commercialization.
  • The patent’s enforceability depends on the novelty, inventive step, and clear claim drafting backed by robust Japanese prior art searches.

4. Patent Mining Tools and Landscape Reports:
Utilizing tools like Derwent Innovation or FTO analyses can map existing patent territories, unveil gaps, and identify potential licensees or infringers.


Legal and Commercial Implications

  • Patent Validity and Enforcement:
    Japanese patent law emphasizes inventive step and novelty; thorough prior art searches validate the patent’s robustness. The scope defined by claims influences enforcement efficacy; narrower claims might reduce invalidation risks but limit market control.

  • Market Exclusivity:
    If the claims are sufficiently broad and well-supported, JP5228488 can secure a dominant market position for its protected compounds or methods, enabling premium pricing and collaboration opportunities.

  • Research and Development (R&D):
    The patent’s scope directly impacts R&D strategies, guiding the design of new derivatives or alternative formulations to avoid infringement or to develop complementary products.


Conclusion

Japan Patent JP5228488 likely covers a specific pharmaceutical compound or formulation planned for therapeutic use, with claims that define its broadest scope and narrower embodiments. Its strategic value hinges on claim language precision, breadth, and the existing patent landscape. For stakeholders, understanding its scope informs R&D direction, licensing, litigation risk assessment, and market entry strategies within Japan and globally.


Key Takeaways

  • Claims Precision: The enforceability and commercial value depend critically on clear, well-structured claims. Broad claims confer extensive protection but require strong support to withstand prior art challenges.

  • Patent Landscape Positioning: A comprehensive landscape review identifies overlapping patents and potential freedom-to-operate issues, guiding licensing or design-around strategies.

  • Global Strategy Alignment: JP5228488's patent family connections highlight the importance of multi-jurisdictional patent protections aligned with Japanese rights.

  • Innovative Edge: The patent underscores innovative pharmaceutical chemistry or methods, potentially enabling exclusivity in a competitive therapeutic class.

  • Legal Vigilance: Ongoing monitoring of patent validity and enforcement in Japan ensures sustained market advantage.


FAQs

1. What is the main innovation protected by JP5228488?
While specific structural details require direct claim review, the patent generally protects a particular chemical entity, formulation, or therapeutic method deemed inventive within the Japanese biotech landscape.

2. How broad are the claims of JP5228488?
The breadth depends on claim drafting—broad claims cover multiple derivatives or uses, while narrower claims focus on specific compounds or methods, affecting enforcement and licensing.

3. Can JP5228488 block competitors from developing similar drugs?
Yes, if claims are sufficiently broad and valid, they can prevent similar inventions based on the claimed compound, composition, or method in Japan.

4. What factors influence the patent’s enforceability in Japan?
Prior art references, clarity of claim language, inventive step, and the patent's maintenance status all impact enforceability.

5. How does the patent landscape affect drug development in Japan?
A crowded patent landscape can complicate freedom-to-operate; strategic patent filing and landscape analysis are essential to mitigate infringement risks.


References

  1. Japan Patent Office (JPO). Official Gazette for JP5228488.
  2. Patent documents and legal analyses relevant to JP5228488.
  3. Related patent families and prior art searches (public patent databases).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.